Announcements Trials
Browse Landscape

Phase

Phase NA 3Phase 2 1Phase 1/2 1

Status

Terminated 1Recruiting 1Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Lymphoid 3Plasma cell 1Other hematologic neoplasm 1Dermatologic 1

Conditions

Carcinoma, Non-Small-Cell Lung 18Breast Neoplasms 15Pancreatic Neoplasms 13Colorectal Neoplasms 10Rectal Neoplasms 7Stomach Neoplasms 6Neoplasm Metastasis 6Lung Neoplasms 6Neoplasms 5Recurrence 4Ovarian Neoplasms 4Uterine Cervical Neoplasms 3Small Cell Lung Carcinoma 3Prostatic Neoplasms 3Lymphoma, T-Cell, Peripheral 3Leukemia, Myeloid, Acute 3Esophageal Squamous Cell Carcinoma 3Colonic Neoplasms 3Urinary Bladder Neoplasms 2Triple Negative Breast Neoplasms 2Treatment 2Solid Tumor 2Small Cell Lung Cancer Limited Stage 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Multiple Myeloma 2Lymphoma 2Head and Neck Neoplasms 2Glioma 2Glioblastoma 2Esophageal Neoplasms 2

Interventions

Whole-Body Irradiation 4Peripheral Blood Stem Cell Transplantation 4Mycophenolic Acid 3Etoposide 3Drug Therapy 3Cyclosporine 3fludarabine phosphate 2Melphalan 2Carmustine 2plerixafor 1monomethyl auristatin E 1Vinorelbine 1VAP-cyclo protocol 1Thiotepa 1O(6)-benzylguanine 1N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 1Leukapheresis 1Immunoconjugates 1Granulocyte Colony-Stimulating Factor 1Gemcitabine 1Filgrastim 1Cytarabine 1Cyclophosphamide 1Carboplatin 1Busulfan 1Brentuximab Vedotin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase NA × Lymphoma, T-Cell, Peripheral × Drug Therapy × Clear all
NCT05444712 2023-09-28

TRANSCRIPT

Hospices Civils de Lyon

Phase NA Recruiting
204 enrolled
Lymphoid

Lymphoma, T-Cell, Peripheral

NCT00003196 2019-12-27

Low-Dose Total Body Irradiation and Donor Peripheral Blood Stem Cell Transplant Followed by Donor Lymphocyte Infusion in Treating Patients With Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, or Multiple Myeloma

Fred Hutchinson Cancer Center

Phase NA Completed
63 enrolled
DermatologicLymphoidOther hematologic neoplasmPlasma cell

Burkitt Lymphoma, Immunoblastic Lymphadenopathy, Leukemia, Hairy Cell, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Waldenstrom Macroglobulinemia, Multiple Myeloma, Mycosis Fungoides, Sezary Syndrome, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell, Cutaneous, Lymphoma, T-Cell, Peripheral, Lymphoma, Large-Cell, Anaplastic, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma, Lymphoma, Extranodal NK-T-Cell, Intraocular Lymphoma

NCT01841021 2017-01-19

Pilot Study of Brentuximab Vedotin in Relapsed/Refractory Peripheral T-Cell Lymphoma Expressing CD30

H. Lee Moffitt Cancer Center and Research Institute

Phase NA Terminated
1 enrolled 5 charts
Lymphoid

Recurrence, Lymphoma, T-Cell, Peripheral

Data powered by HemOnc (CC BY 4.0) Colophon âš¡